Intravascular Imaging Insights into the Mechanism of Action of Focal Force Balloon Angioplasty

Similar documents
Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

Dealing with Calcification in BTK Arteries: Is Lithoplasty the Answer?

Shockwave Intravascular Lithotripsy System treatment of calcified lesions: Intravascular OCT analysis

Final Results of the Feasibility Study for the Drug-coated Chocolate Touch PTA balloon. (The ENDURE Trial)

CLI Treatment Using Long and Scoring Balloons

One Year after In.Pact Deep: Lessons learned from a failed trial. Prof. Dr. Thomas Zeller

Clinical benefits on DES Patient s perspectives

Future Algorithm for Lower Extremity Revascularization: Where Does Vessel Prep Fit?

Drug-coated balloons in BTK:

Lessons learnt from DES in the SFA is there any ideal concept so far?

Angiographic dissection pattern and patency outcomes of post balloon angioplasty for SFA lesions -a retrospective multi center analysis-

Update on Tack Optimized Balloon Angioplasty (TOBA) Below the Knee. Marianne Brodmann, MD Medical University Graz Graz, Austria

Promise and limitations of DCB in long lesions What Have we Learned from Clinical Trials? Ramon L. Varcoe, MBBS, MS, FRACS, PhD

Present & future of below the knee stenting

Is combination therapy with directional atherectomy followed by DCB the answer to challenges in treating SFA disease?

The Role of Lithotripsy in Solving the Challenges of Vascular Calcium. Thomas Zeller, MD

The essentials for BTK procedures: wires, balloons, what else

ISR-treatment The Leipzig experience with purely mechanical debulking. Sven Bräunlich Department for Angiology University-Hospital Leipzig, Germany

Endovascular Options in Critical Limb Ischemia: Below The Knee Therapies

Expanding to every demand: The GORE VIABAHN VBX Stent Graft

Calcified lesions optimal treatment

Christian Wissgott MD, PhD Assistant Director, Radiology Westküstenkliniken Heide

Shockwave Medical Lithoplasty. Thomas Zeller MD Universitäts-Herzzentrum Freiburg & Bad Krozingen, Germany

Treatment Strategies for Long Lesions of greater than 20 cm

Making BTK Interventions more Durable: Are DES and DCB the answer? Thomas Zeller, MD

Fabrizio Fanelli, MD, EBIR Director Vascular and Interventional Radiology Department "Careggi " University Hospital Florence - Italy

Lessons & Perspectives: What is the role of Cryoplasty in SFA Intervention?

Klinikum Rosenheim Department of Diagnostic and Interventional Radiology

The role of bioabsorbable stents in the superficial femoral artery What is going on? Frank Vermassen Ghent University Hospital Belgium

First time data release: Initial experience with the temporary Spur Stent System: DEEPER Trial first-in-man results Jihad A. Mustapha, MD, FACC,

Advancing treatment in highly complex lesions evidence and practice. Arne Schwindt St. Franziskushospital Münster

Clinically proven. ordering info. Vascular Intervention // Peripheral Self-Expanding Stent System/0.018 /OTW. Pulsar-18

Rationale and algorithm for below-the-knee acute gain optimization

Utility of Image-Guided Atherectomy for Optimal Treatment of Ambiguous Lesions by Angiography

What Coronary Specialists Teach The Vascular Community About Vessel Prep? Tony Das, MD Texas Health, Dallas Dallas, Texas

The Crack and Pave technique for highly resistant calcified lesions. Manuela Matschuck MD University Hospital Leipzig Department Angiology

Outcomes Of DCB Use In Real World Registries: 2 Year Results From The INPACT Global Registry

Specificities for infrapopliteal stents

PES BTK 70 : 12 m results with a paclitaxelcoated self-expanding stent in BTK arteries

Efficacy of DEB in Calcification and Subintimal Angioplasty

Koen Keirse, MD RZ Tienen, Belgium

Merits and demerits of DES, DEB or covered stent in lower extremity arterial occlusive disease 성균관의과대학삼성서울병원순환기내과최승혁

Update from Korea on the Lutonix SFA registry 12 month data

Which Stent Is Best for Various Femoropopliteal Anatomy? 2018 Pacific Northwest Endovascular Conference June 15-26, 2018 Seattle, WA

TOBA Trial 12 months Results

Drug delivery devices for BTK treatment

The present status of selfexpanding. for CLI: Why and when to use. Sean P Lyden MD Cleveland Clinic Cleveland, Ohio

Initial Clinical Experience with a Novel Dedicated Cobalt Chromium Stent for the Treatment of Below-the-knee Arterial Disease

New Evidence from Laser + Drug Coated Balloons for Treatment of In-Stent Restenosis

In-Stent Restenosis: New Evidence From Laser + Drug Coated Balloons

2-YEAR DATA SUPERA POPLITEAL REAL WORLD

Considerations for the Near Future of Drug Delivery Devices Below the Knee

Stents for The Common Femoral Artery: The Good, The Bad and The Ugly

MEET M. Bosiers K. Deloose P. Peeters. SFA stenting in 2009 : The good and the ugly What factors influence patency?

RELINE-trial : 24 months results with the Viabahn vs PTA for in-stent restenosis

Endovascular treatment of infrapopliteal arteries: angioplasty vs stent in the drug-eluting era

Comparison of Angiographic Dissection Patterns Caused by Long vs Short Balloons During Balloon Angioplasty for Chronic Femoropopliteal Occlusions

Clinical Data Update for Drug Coated Balloons (DCB) Seung-Whan Lee, MD, PhD

Vessel preparation with scoring balloons prior to DCB or stenting

The LIMBO trial: a RCT investigating adventitial dexamethasone infusion to prevent restenosis in BTK arteries utilizing a novel angiographic endpoint

Photoablation and DCB in in-stent restenosis

PATIENTS WITH CLI THE THREE YEARS OUTCOME OF ENDOLUMINAL BYPASS FOR PATIENTS WITH CLI

Latest Insights from the LEVANT II study and sub-group analysis

Atherectomy: Jetstream and Directional. George S. Chrysant, M.D.

Adventitial Drug Therapy Below-the-Knee: Update on LIMBO and TANGO

Drug Eluting Stents: Update

DCB in my practice: How the evidence influences my strategy. Yang-Jin Park

Is a Stent or Scaffold Necessary in The SFA?

Update on the OPTIMIZE BTK Trial. Marianne Brodmann, MD Division of Angiology Medical University Graz, Austria

The TANGO Trial: A phase II below-the-knee study investigating the adventitial micro-infusion of Temsirolimus after PTA or atherectomy

Pulsar stent technology

Update in femoral angioplasty & stenting PRO

How do I use mechanical debulking for the treatment of arterial occlusions

Drug-Coated Balloon Treatment for Patients with Intermittent Claudication: Insights from the IN.PACT Global Full Clinical Cohort

Innovation by design. Technology that sets a new standard

Konstantinos Katsanos, MSc, MD, PhD, EBIR. Consultant Interventional Radiologist Guy's and St.Thomas' Hospitals, NHS Foundation Trust

Hiroshi Ando, MD Kasukabe Chuo General Hospital Saitama, Japan

The Lutonix BTK Clinical Trial Programme: Status Update and Real World Clinical Experience

Safety and Feasibility of Intravascular Lithotripsy for Treatment of Common Femoral Artery Stenoses

Aggressive BTK Revascularization and Advanced Wound Care - Patient Specific Therapy Concepts

Importance of Thorough Vessel Preparation Followed By Anti- Restenotic Therapy: An Update from the DEFINITIVE AR Study

Could a combination of DCB + stent be the answer in complex SFA lesions

Orbital Atherectomy. S. Jay Mathews, MD, MS, FACC Interventional Cardiologist, Bradenton Cardiology Center

Why and how to prep the vessel

LUTONIX DCB in BTK Update on the BTK clinical program & single center experience

Plaque scoring in calcified lesions

Comparison Of Primary Long Stenting Versus Primary Short Stenting For Long Femoropopliteal Artery Disease (PARADE)

Use of Laser In BTK Disease (CLI)

TOBA II 12-Month Results Tack Optimized Balloon Angioplasty

Evolving Role of Drug-Eluting Stents In Complex SFA - Majestic Trial Data

Vessel Preparation Prior to DCB and Stenting: How to Do It.

Treatment of Complex Atherosclerotic Popliteal Artery Disease With a New Self-Expanding Interwoven Nitinol Stent

Calcium Removal and Plaque Modification in the Era of DEB and Contemporary Stenting for Femoro- Popliteal Disease

Robert W. Fincher, DO The Ritz-Carlton, Dove Mountain Marana, Arizona February 7th, 2015

Drug-Eluting Balloon Angioplasty versus Bare Metal Stents for Femoropopliteal Disease in Real-World Experience

Is there a place for very distal BTK stenting? What are the options for acute PTA failure?

Drug- Coated Balloons for the SFA: Overview of Technology and Results

Adventitial Drug Therapy for Critical Limb Ischemia

Minimizing Burden, the effect of thin strut and low Chronic Outward Force SE stents

Update on the role of drug eluting balloons

Transcription:

LINC 2015 Global Expert Exchange Forum January 28, 2015 Intravascular Imaging Insights into the Mechanism of Action of Focal Force Balloon Angioplasty Sahil A. Parikh, M.D. Assistant Professor of Medicine Director, Research and Innovation Center Director, Experimental Interventional Cardiology Laboratory Director, Interventional Cardiology Fellowship Program Harrington Heart & Vascular Institute University Hospitals Case Medical Center Case Western Reserve University School of Medicine

Disclosure Speaker name: Sahil A. Parikh, MD I have the following potential conflicts of interest to report: x Consulting: Angioscore/Spectranetics, TriReme, Cordis, St. Jude Employment in industry Stockholder of a healthcare company Owner of a healthcare company Other(s) I do not have any potential conflict of interest

Short Segment Occlusion PTA: Satisfactory Angiographic Result?

OCT of TP Trunk Post PTA Sahil A. Parikh, MD

POBA Mechanism of Action Plaque Sheer Stress Formation Plaque Dissection Plaque Folded Half-way Balloon Inflated Balloon Pre-Inflation During Inflation End of Inflation Inflated Balloon MoA 1: Unfolding expansion results in: Shear stress MoA 2: Uncontrolled expansion results in: Dilatation in path of least resistance MoA 1 + 2 = Vessel Trauma (torsional, radial, longitudinal) Vessel trauma manifests as: Severe dissections Elastic recoil Abrupt closure Today s solution: STENTS

Chocolate Design and MoA Goal: Provide stent-like results without permanent implant Design by TriReme Medical: Unique nitinol constraining structure Shields vessel wall from torsional shear stress caused by balloon unfolding Uniformly distributes longitudinal & circumferential forces Modifies plaque via: Modules : Vessel dilatation without cutting or scoring Grooves : Stress relief, plaque modification Reduces dissections Fast deflation, concentric secondary profile MRK394 rev A Grooves [Modules project beyond constraining structure]

Balloon Effect on Simulated Artery Finite Element Analysis Computer Images PTA Balloon Chocolate Balloon Scoring Balloon Plaque High Stress Plaque High Stress Plaque High Stress Low Stress Low Stress Low Stress FEA simulation shows significantly less vessel trauma vs. alternatives Courtesy: TriReme Medical

BTK Procedural Success No Flow Limiting Dissection Achieved <30% Diameter Stenosis physician visual estimate Freedom from Bail-Out Stenting Dissection Rates N=174 99% (173/174) 94% (163/174) 97% (168/174) Bail-Out Stenting Rates 12% 20% How does this compare? 1% 8% 3% 5% 12% 14% Chocolate BAR Odink, PTA Study Bosiers, PTA Arm Chocolate BAR Schmidt Bosiers, BTK DEB PTA Arm Odink H, van den Berg A, Winkens B. Technical and clinical long-term results of infrapopliteal percutaneous transluminal angioplasty for critical limb ischemia. J Vasc Inter radio. Apr 2012: 23(4):461-467 Schmidt BTK PTA Odink, PTA Study Boisers M, Scheinert D, Peetrs P, Torsello G, Zeller T, Delosse K, Schmidt A, Tosserek J, Vinck E, Schwartz L. Randomized comparison of everolimus-eluting versus bare-metal stents in patients with critical limb ischemia and infrapopliteal arterial occlusive disease. J Vasc Surg Feb 201255(2):390-398 Schmidt A, Piorkowski M, Werner M, Ulrich M, Bausback Y, Braunlich S, Ick H, Schuster J, Botsios S, Kruse H, Varcoe R, Scheinert D. First Experience with Drug-Eluting Balloons in Infrapopliteal Arteries. JACC Sep 2011 58(11): 1105-1109 Schmidt A, Ulrich M, Winkler B, Klaeffling C, Bausback Y, Braunlich S, Botsios S, Kruse H, Varcoe R, Scheinert D. Angiographic Patency and Clinical Outcome After Balloon-Angioplasty for Extensive Infrapopliteal Arterial Disease. Courtesy: Tony Das and Jihad Mustapha, LINC 2014

Plaque Composition Courtesy: Hiram Bezerra, MD and Marco Costa, MD, PhD

Angioplasty of Calcified Lesions: Fracture Courtesy: Hiram Bezerra, MD and Marco Costa, MD, PhD No Fracture: Dissection Partial Calcium Fracture Complete Calcium Fracture

Case Example: Lipid Rich Plaque with Medial Calcification

Treatment with Chocolate 4.0x40mm

Localized Dissection without Extension

Case Example: Calcified Lesion

Case Example: Fibrotic LesionAnastomosis

Numerous Examples

CONCLUSIONS Focal Force Balloons have a unique mechanism of action compared to conventional PTA balloons These devices demonstrate good acute performance in ATK and BTK lesions when looking at registry data in a representative group of patients Heterogenous lesion composition confounds our ability to identify specific lesion types which may be particularly well-suited to treatment with these devices Imaging analysis suggests less intimal disruption Chocolate OCT: ClinicalTrials.Gov: NCT02237066

LINC 2015 Global Expert Exchange Forum January 28, 2015 Intravascular Imaging Insights into the Mechanism of Action of Focal Force Balloon Angioplasty Sahil A. Parikh, M.D. Assistant Professor of Medicine Director, Research and Innovation Center Director, Experimental Interventional Cardiology Laboratory Director, Interventional Cardiology Fellowship Program Harrington Heart & Vascular Institute University Hospitals Case Medical Center Case Western Reserve University School of Medicine